CFDB - Cystic Fibrosis DataBase

primary studies published RCT

Coping and learning to Manage Stress with cystic fibrosis (CALM): A multisite telehealth randomized controlled trial to reduce depression and anxiety symptoms in adults with cystic fibrosis.

Study design (if review, criteria of inclusion for studies)

Randomized controlled trial

Participants

Adults with cystic fibrosis reporting mild to severe symptoms of depression and/or anxiety

Interventions

"Coping and Learning to Manage Stress with CF" (CALM). Patients were randomized to receive CALM immediately (immediate, n = 66) or after a 13-week delay (waitlist, n = 66).

Outcome measures

Depression and anxiety symptoms. Maintenance of treatment gains from baseline to 3-month follow-up

Main results

Compared to the waitlist group, those that received CALM immediately reported lower depression and anxiety symptoms post-intervention and at 1-month follow-up (ps<0.001). For depression there was a large effect size post-intervention (d = 0.85) and a medium effect size at 1-month follow-up (d = 0.70); anxiety had a medium effect size post-intervention (d = 0.65) and at 1-month follow-up (d = 0.66). The immediate group also reported significantly higher coping self-efficacy, less stress, and increased vitality post-CALM and at 1-month follow-up (ps<0.01). Treatment gains were maintained at 3-month follow-up for all outcomes.

Authors' conclusions

CALM was efficacious for Adults with cystic fibrosis in reducing symptoms of depression, anxiety, and perceived stress while improving coping self-efficacy and vitality with evidence of treatment sustainability. Next steps are dissemination and implementation to CF psychosocial clinicians.

Keywords: Adult; Child; Adolescent; Caregivers; Home; Home Care Services; non pharmacological intervention - psyco-soc-edu-org; telemedicine; Organization;